Simultaneous separation and detection of nine kynurenine pathway metabolites by reversed-phase liquid chromatography-mass spectrometry: Quantitation of inflammation in human cerebrospinal fluid and plasma
Analytica Chimica Acta · 2023-10 · 1278 · 341659
DOI: 10.1016/j.aca.2023.341659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023-10. Verfasst von Vijay D Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Georgia State University, Atlanta, GA, 30303, USA. Hauptthemen laut MEDLINE: Chromatography, Reverse-Phase, Kynurenine. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
BACKGROUND: The kynurenine pathway (KP) generates eight tryptophan (TRP) metabolites collectively called kynurenines, which have gained enormous interest in clinical research. The importance of KP for different disease states calls for developing a low-cost and high-throughput chromatography-mass spectrometry method to evaluate the potential of different kynurenines. Simultaneous separation of TRP and its eight metabolites is challenging because they have substantial polarity differences (log P = -2.5 to +1.3). RESULTS: A low-cost, reversed-phase LC-MS/MS method based on polarity partitioning was established to simultaneously separate and quantitate all nine kynurenine pathway metabolites (KPMs) in a single run for the first time in the open literature. Based on stationary phase screening and ternary mobile phase optimization strategy, high polarity KPMs were retained while medium and low polarity KPMs were eluted in a shorter time. After method validation, we demonstrated the applicability of this LC/MS/MS method by quantitative measurement of all nine KPM in cerebrospinal fluid (CSF) and plasma among two groups of human subjects diagnosed with depression. Furthermore, we measured the differential KPMs in these two groups of low and high inflammation and correlated the results with CRP or TNF-α markers for depression. SIGNIFICANCE: Our proposed LC-MS/MS provides a new metabolite assay that can be easily applied in various clinical applications to simultaneously quantify multiple biomarkers in KP dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Georgia State University, Atlanta, GA, 30303, USA.
- Department of Chemistry, Georgia State University, Atlanta, GA, 30303, USA. Electronic address: sshamsi@gsu.edu.
- Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, 30322, USA.
- Department of Chemistry, The University of Texas at San Antonio, San Antonio, TX, 78249, USA.
- Agilent Technologies, Wilmington, DE, 19808, USA.
Förderung
- NIMH NIH HHS
- National Institutes of Health
Zitieren
APA
Patel, V. D., Shamsi, S. A., Miller, A., Liu, A., & Powell, M. (2023). Simultaneous separation and detection of nine kynurenine pathway metabolites by reversed-phase liquid chromatography-mass spectrometry: Quantitation of inflammation in human cerebrospinal fluid and plasma. Analytica Chimica Acta, 1278, 341659. https://doi.org/10.1016/j.aca.2023.341659
Vancouver
Patel VD, Shamsi SA, Miller A, Liu A, Powell M. Simultaneous separation and detection of nine kynurenine pathway metabolites by reversed-phase liquid chromatography-mass spectrometry: Quantitation of inflammation in human cerebrospinal fluid and plasma. Analytica Chimica Acta. 2023;1278:341659. doi:10.1016/j.aca.2023.341659
BibTeX
@article{Patel2023,
author = {Patel, Vijay D and Shamsi, Shahab A and Miller, Andrew and Liu, Aimin and Powell, Mark},
title = {Simultaneous separation and detection of nine kynurenine pathway metabolites by reversed-phase liquid chromatography-mass spectrometry: Quantitation of inflammation in human cerebrospinal fluid and plasma},
journal = {Analytica Chimica Acta},
year = {2023},
volume = {1278},
pages = {341659},
doi = {10.1016/j.aca.2023.341659}
}
EUVIMED